Evidence map›Paper›PMID 39475511›Full record

ArticleCell reports2024

Muscle inflammation is regulated by NF-κB from multiple cells to control distinct states of wasting in cancer cachexia.

Benjamin R Pryce, Alexander Oles, Erin E Talbert, Martin J Romeo, Silvia Vaena, Sudarshana Sharma, Victoria Spadafora, Lauren Tolliver, David A Mahvi, Katherine A Morgan and 15 more

Abstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The effects of tissue inflammation on cancer cachexia.Biochimica et biophysica acta. Molecular basis of disease · 2026
    Review
  13. Review
  14. Article
  15. Review
  16. Cancer cachexia: molecular basis and therapeutic advances.Signal transduction and targeted therapy · 2026
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Benjamin R PryceDepartment of Pediatrics, Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425, USA.
Alexander OlesDepartment of Pediatrics, Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425, USA.
Erin E TalbertDepartment of Pediatrics, Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425, USA; Department of Health and Human Physiology, and the Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA.
Martin J RomeoHollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Silvia VaenaHollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.
Sudarshana SharmaDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Victoria SpadaforaDepartment of Pediatrics, Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425, USA.
Lauren TolliverDepartment of Pediatrics, Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425, USA.
David A MahviDepartment of Surgery, Medical University of South Carolina, Charleston, SC 29403, USA.
Katherine A MorganDepartment of Surgery, Medical University of South Carolina, Charleston, SC 29403, USA.
William P LancasterDepartment of Surgery, Medical University of South Carolina, Charleston, SC 29403, USA.
Eryn BealDepartment of Surgery, Medical University of South Carolina, Charleston, SC 29403, USA.
Natlie KorenDepartment of Surgery, Medical University of South Carolina, Charleston, SC 29403, USA.
Bailey WattsDepartment of Surgery, Medical University of South Carolina, Charleston, SC 29403, USA.
Morgan OverstreetDepartment of Surgery, Medical University of South Carolina, Charleston, SC 29403, USA.
Stefano BertoDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC 29425, USA.
Suganya SubramanianDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC 29425, USA.
Kubra CalisirDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Anna CrawfordHollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
Brian NeelonHollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
Michael C OstrowskiHollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Teresa A ZimmersDepartment of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Portland, Oregon Health Science University, Portland, OR 97239, USA.
James G TidballDepartment of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, CA 90095, USA.
David J WangDepartment of Pediatrics, Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425, USA.
Denis C GuttridgeDepartment of Pediatrics, Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425, USA; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA. Electronic address: guttridg@musc.edu.

Funding

Tumor Microenvironment and Metastasis ProgramP30CA082709 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI David W Clapp · 1999 to 2026
$59.3M
Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J Lemasters · 2009 to 2026
$42.7M
The Role of Early Life Stress in Feeding BehaviorsP20GM148302 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jose H Ledo · 2023 to 2026
$11.5M
The role of the macroenvironment in pancreatic cancer-induced cachexiaP01CA236778 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GUTTRIDGE, DENIS C · 2021 to 2025
$9.7M
NF-kB Regulation of the Muscle Microenvironment in Cancer CachexiaR01AR072714 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GUTTRIDGE, DENIS C · 2020 to 2024
$2.3M
Manipulation of STAT3 Signaling for Muscle Preservation in Cancer CachexiaR01CA122596 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZIMMERS, TERESA A · 2010 to 2015
$1.6M
PQB3: Mechanisms & Targeting of Sonic Hedgehog Signaling in Muscle Wasting of Cancer CachexiaR01CA194593 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI ZIMMERS, TERESA A · 2015 to 2018
$1.4M
The Extracellular Matrix in Muscle AtrophyR00AR071508 · NIAMS · UNIVERSITY OF IOWA · PI TALBERT, ERIN E · 2020 to 2022
$737k
The Extracellular Matrix in Muscle AtrophyK99AR071508 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TALBERT, ERIN E · 2018 to 2019
$189k
Elucidating the survival mechanisms of rhabdomyosarcomaF30CA265071 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OLES, ALEXANDER R. · 2022 to 2023
$99k
BLRD VA I01 BX004177CSRD VA I01 CX002046NCI NIH HHS F30 CA265071NCI NIH HHS P01 CA236778NCI NIH HHS P30 CA082709NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA122596NCI NIH HHS R01 CA194593NIAMS NIH HHS K99 AR071508NIAMS NIH HHS R00 AR071508NIAMS NIH HHS R01 AR072714NIGMS NIH HHS P20 GM148302
6 · The paper itself

Abstract

Although cancer cachexia is classically characterized as a systemic inflammatory disorder, emerging evidence indicates that weight loss also associates with local tissue inflammation. We queried the regulation of this inflammation and its causality to cachexia by exploring skeletal muscle, whose atrophy strongly associates with poor outcomes. Using multiple mouse models and patient samples, we show that cachectic muscle is marked by enhanced innate immunity. Nuclear factor κB (NF-κB) activity in multiple cells, including satellite cells, myofibers, and fibro-adipogenic progenitors, promotes macrophage expansion equally derived from infiltrating monocytes and resident cells. Moreover, NF-κB-activated cells and macrophages undergo crosstalk; NF-κB

Indexed as

CachexiaInflammationMacrophagesMuscle, SkeletalNeoplasmsNF-kappa BAnimalsHumansMaleMiceMice, Inbred C57BLMuscular AtrophyNF-kappa Bcancer cachexiaCP: CancerCP: Immunologyfibro-adipogenic progenitorsmacrophagesmuscle progenitor cellsNF-κBpancreatic cancer

Identifiers

PMID39475511
PMCPMC11774514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.